CynthiaLynnJohnsonMD

PubMed

• 17 citations
  Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy
  Steven Black, Henry R. Shinefield, Paula Ray, Edwin Lewis, Bruce Fireman, Robert A. Hiatt, Dace V. Madore, Cynthia L. Johnson, Jill G. Hackell> ;The Pediatric Infectious Disease Journal. 1993 Dec 1
• 11 citations
  Response of 7- to 15-Month-Old Infants to Sequential Immunization With Haemophilus influenzae Type b-CRM197 Conjugate and Polysaccharide Vaccines
  Edward P. Rothstein, Ruth P. Schiller, Joseph A. C. Girone, Thomas J. Hipp, Ronald L. Souder, Henry H. Bernstein, Dace V. Madore, Cynthia L. Johnson, David H. Smith> ;American Journal of Diseases of Children. 1991 Aug 1
• 33 citations
  Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
  Dace V. Madore, Cynthia L. Johnson, Donna C. Phipps, Martin G. Myers, Ronald John Eby, David H. Smith> ;Pediatrics. 1990 Oct 1
• 65 citations
  Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.
  Dace V. Madore, Cynthia L. Johnson, Donna C. Phipps, Lou A Popejoy, Ronald John Eby, David H. Smith> ;Pediatrics. 1990 Mar 1
• 7 citations
  Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report.
  David H. Smith, Dace V. Madore, Ronald John Eby, Porter Anderson, Richard A. Insel, Cynthia L. Johnson> ;Advances in Experimental Medicine and Biology. 1989 Jan 1
• Join now to see all